Last updated: August 12, 2024
Sponsor: University of Chicago
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hernia
Treatment
POSTERIOR RECTUS SHEATH HIATAL AUGMENTATION (PORSHA)
Clinical Study ID
NCT06551077
IRB24-0322
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients undergoing PoRSHA. PoRSHA will be offered to all patients with PEHdefects measuring greater than 4 cm.
Exclusion
Exclusion Criteria:
Patients that did not have PoRSHA.
Patients requiring therapeutic anticoagulation perioperatively or those withbleeding disorders, considering the added risk of bleeding at the donor site withexposed rectus muscle.
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: POSTERIOR RECTUS SHEATH HIATAL AUGMENTATION (PORSHA)
Phase:
Study Start date:
May 15, 2024
Estimated Completion Date:
May 31, 2029
Study Description
Connect with a study center
The University of Chicago
Chicago, Illinois 60637
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.